ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Clinical performance and quality measures for heart failure management in China: the China-Heart Failure registry study

Zhang, Yuhui; Gao, Chuanyu; Greene, Stephen J.; Greenberg, Barry H.; Butler, Javed; Yu, Jing; Zheng, Zhaofen; Ma, Genshan; Wang, Lian; Yang, Ping; Ji, Xiaoping; Xu, Dingli; Wang, Jiang; Zhang, Yao; Liu, Ying; Zhao, Yan; Qi, Hong; Zhai, Mei; Feng, Jiayu; Huang, Yan; Zhou, Qiong; Zhang, Jian*吉林大学; 南方医科大学; 南京大学; 山东大学; 兰州大学; 哈尔滨医科大学; 郑州大学; 中国医学科学院; 1
ESC Heart Failure2023-2DOI: 10.1002/ehf2.14184
2被引24阅读
引用收藏
分享

摘要

Aims Heart failure (HF) remains a major public health problem with increasing prevalence in China. This study evaluated the clinical performance and quality measures for HF management to identify gaps in the standardization of care for patients hospitalized for HF in China. @@@ Methods and results Following the results of China-HF stage 1(2012-2015), the second stage of the China-HF was launched in 2017. Among 113 hospitals with >= 100 cases, the China-HF Stage II assessed the quality of care measures for HF and compared results with previous data in China and the US-based Get with The Guidelines-Heart Failure (GWTG-HF) registries. In total, 34 938 patients hospitalized with HF were enrolled from January 2017 to October 2020. Echocardiographic left ventricular function and natriuretic peptide test were performed in 93.7% and 93.0% of the cases, respectively. Adherence to standardized guidelines in China-HF stage II was higher than that in the China-HF stage I, but generally lower than GWTG-HF registry with 78.2% of eligible patients was prescribed oral diuretics, 78.7% renin-angiotensin-system inhibitors, and 82.2% beta-blockers. Implantable cardioverter-defibrillators and cardiac resynchronization devices were implanted in 3.9% and 14.6%, respectively. In contrast, the proportion of eligible patients discharged with spironolactone (87.8%) was higher than GWTG-HF. The median length of hospitalization was 9 (6, 12) days, and 938 (2.8%) patients died or withdrew from treatment during hospitalization. @@@ Conclusions Despite significant improvements in the use of guideline-recommended testing and therapy, there remain major gaps in quality of care for patients hospitalized for HF in China that are generally larger than gaps observed in the United States.

学科与关键词

关键词
Heart failureMedical unionClinical performanceQuality measuresQuality improvement
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
ESC Heart Failure
发表日期
2023-02
卷期
第 10 卷, 第 1 期
页码
342-352
DOI
10.1002/ehf2.14184
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2017YFC1308301, 2017YFC1308305]

作者

  • Z

    Zhang, Yuhui (第一作者)

    chinese acad med sci · peking union med coll, fuwai hosp

  • G

    Gao, Chuanyu

    henan prov peoples hosp · zhengzhou univ · fuwai hosp

查看全部 22 位作者收起作者
  • G

    Greene, Stephen J.

  • G

    Greenberg, Barry H.

  • B

    Butler, Javed

  • Y

    Yu, Jing

    2 · lanzhou univ

  • Z

    Zheng, Zhaofen

    1 · hunan normal univ · hunan prov peoples hosp

  • M

    Ma, Genshan

    southeast univ

  • W

    Wang, Lian

    nanjing univ

  • Y

    Yang, Ping

    jilin univ

  • J

    Ji, Xiaoping

    shandong univ

  • X

    Xu, Dingli

    southern med univ

  • W

    Wang, Jiang

    xinqiao hosp

  • Z

    Zhang, Yao

    harbin med univ · 2

  • L

    Liu, Ying

    1 · dalian med univ

  • Z

    Zhao, Yan

    first peoples hosp yunnan prov

  • Q

    Qi, Hong

    chifeng coll

  • Z

    Zhai, Mei

    chinese acad med sci · peking union med coll, fuwai hosp

  • F

    Feng, Jiayu

    chinese acad med sci · peking union med coll, fuwai hosp

  • H

    Huang, Yan

    chinese acad med sci · peking union med coll, fuwai hosp

  • Z

    Zhou, Qiong

    chinese acad med sci · peking union med coll, fuwai hosp

  • Z

    Zhang, Jian (通讯)

    chinese acad med sci · peking union med coll, fuwai hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417